Clinical trial Recruiting at 1 site Interventional Ages 8 and up

Effects of stenting on exercise capacity in patients with certain congenital heart defects

Official title: The Effects of Branch Pulmonary Artery Stenting in d-TGA, ToF and TA: a Randomized Control Trial

Run by UMC Utrecht · NCT05809310 · Data updated 2026-11-12

This study is testing if a procedure to open blocked arteries can help people with certain heart defects, like d-TGA, ToF, and TA, exercise better.

More Congenital Heart Disease trials

Quick facts

Study typeInterventional
Ages8 Years and up
SexAll
Enrollment56 (estimated)
SponsorUMC Utrecht
Academic / other
Locations4 sites (Amsterdam and 3 other locations)
StatusRecruiting
StartedApril 18, 2023
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 30, 2025
Trial IDNCT05809310 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 8 years and older with d-TGA post arterial switch operation, ToF, or TA.

Probably not a fit

Patients with significant comorbidities or severe right ventricular dysfunction may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the impact of percutaneous interventions for branch pulmonary artery stenosis on exercise capacity in patients with dextro transposition of the great arteries (d-TGA), Tetralogy of Fallot (ToF), and Truncus Arteriosus (TA). Participants will undergo a series of examinations, including echocardiograms and cardiopulmonary exercise testing, at baseline and approximately six months later. The study also seeks to assess right ventricular function and identify early markers for improving the timing of these interventions. It is a multicenter randomized controlled trial conducted across several Dutch interventional centers.

Why it matters

Potential benefit: If successful, this study could enhance exercise capacity and overall quality of life for patients with specific congenital heart defects.

How similar studies have gone: While the effects of percutaneous interventions for branch PA stenosis are not well-established, similar approaches in other studies have shown promise in improving outcomes for patients with congenital heart defects.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

* Patients with d-TGA post ASO, ToF or TA
* ≥8 years

Exclusion Criteria:

One or more of the following inclusion criteria:

* All class IIa indications for a branch PA intervention:
* Persistent decreased RV function (based on gold standard CMR)

  * \<18 years RVEF ≤55% (28)
  * ≥18 years RVEF\<50% (29)
* Progressive tricuspid regurgitation (TR) (≥moderate)
* Isolated bifurcation stenosis:

  * Significant unilateral stenosis (≥50%)
  * Borderline bilateral PA stenosis (40-70%)
* Unbalanced perfusion (≤35/65%)
* RV/LV pressure ratio \> 2/3 based on echocardiography
* Reduced lung perfusion or decreased objective exercise capacity (based of gold standard VO2 max during CPET)

  * \<18 years VO2 peak \<35 mL∙kg-1∙min-1 (boys) VO2 peak \<30 mL∙kg-1∙min-1 (girls) (30)
  * ≥18 years VO2 peak \<27 mL∙kg-1∙min-1 (men) VO2 peak \<19 mL∙kg-1∙min-1 (women) (31)

Where it's running

  • UMC Utrecht/WKZ
    Utrecht, Netherlands
    Recruiting
  • Amsterdam University Medical Center location AMC
    Amsterdam, Netherlands
    Not yet recruiting
  • Leiden University Medical Center
    Leiden, Netherlands
    Not yet recruiting
  • Erasmus Medical Center
    Rotterdam, Netherlands
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.